These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1022 related articles for article (PubMed ID: 27299887)

  • 1. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.
    Ito S; Sano T; Mizusawa J; Takahari D; Katayama H; Katai H; Kawashima Y; Kinoshita T; Terashima M; Nashimoto A; Nakamori M; Onaya H; Sasako M
    Gastric Cancer; 2017 Mar; 20(2):322-331. PubMed ID: 27299887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrectomy with D2 lymph node dissection for high-risk advanced gastric cancer: results of the KDOG1001 trial.
    Hosoda K; Azuma M; Katada C; Moriya H; Mieno H; Ishido K; Ema A; Ushiku H; Wada T; Washio M; Watanabe A; Higuchi K; Tanabe S; Koizumi W; Watanabe M; Yamashita K
    Gastric Cancer; 2019 May; 22(3):598-606. PubMed ID: 30284080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
    Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
    Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of preoperative docetaxel with cisplatin plus S-1 therapy for gastric cancer with extensive nodal metastasis (JCOG1002).
    Takahari D; Ito S; Mizusawa J; Katayama H; Terashima M; Sasako M; Morita S; Nomura T; Yamada M; Fujiwara Y; Kimura Y; Ikeda A; Kadokawa Y; Sano T;
    Gastric Cancer; 2020 Mar; 23(2):293-299. PubMed ID: 31515693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.
    Oyama K; Fushida S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Nakagawara H; Tajima H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Tani T; Fujimura T; Ohta T
    J Surg Oncol; 2012 May; 105(6):535-41. PubMed ID: 22006649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases.
    Fushida S; Fujimura T; Oyama K; Yagi Y; Kinoshita J; Ohta T
    Anticancer Drugs; 2009 Sep; 20(8):752-6. PubMed ID: 19543076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase II study of systemic chemotherapy with docetaxel, cisplatin, and S-1 (DCS) followed by surgery in gastric cancer patients with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1002.
    Katayama H; Ito S; Sano T; Takahari D; Mizusawa J; Boku N; Tsuburaya A; Terashima M; Sasako M;
    Jpn J Clin Oncol; 2012 Jun; 42(6):556-9. PubMed ID: 22525210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
    Inoue K; Nakane Y; Kogire M; Fujitani K; Kimura Y; Imamura H; Tamura S; Okano S; Kwon AH; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
    Eur J Surg Oncol; 2012 Feb; 38(2):143-9. PubMed ID: 22154885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy combining docetaxel, cisplatin and S-1 in gastric cancer with para-aortic lymph node metastases: report of five cases.
    Fushida S; Fujimura T; Oyama K; Kinoshita J; Fujita H; Ninomiya I; Ohta T
    Hepatogastroenterology; 2010; 57(104):1650-4. PubMed ID: 21443137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of docetaxel and S-1 (DS) as neoadjuvant chemotherapy for clinical stage III resectable gastric cancer.
    Oki E; Emi Y; Kusumoto T; Sakaguchi Y; Yamamoto M; Sadanaga N; Shimokawa M; Yamanaka T; Saeki H; Morita M; Takahashi I; Hirabayashi N; Sakai K; Orita H; Aishima S; Kakeji Y; Yamaguchi K; Yoshida K; Baba H; Maehara Y
    Ann Surg Oncol; 2014 Jul; 21(7):2340-6. PubMed ID: 24604583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated analysis of two phase II trials (JCOG0001 and JCOG0405) of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer with extensive lymph node metastasis.
    Katayama H; Tsuburaya A; Mizusawa J; Nakamura K; Katai H; Imamura H; Nashimoto A; Fukushima N; Sano T; Sasako M
    Gastric Cancer; 2019 Nov; 22(6):1301-1307. PubMed ID: 31264058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer.
    Mieno H; Yamashita K; Hosoda K; Moriya H; Higuchi K; Azuma M; Komori S; Yoshida T; Tanabe S; Koizumi W; Katada N; Watanabe M
    Surg Today; 2017 Oct; 47(10):1249-1258. PubMed ID: 28365892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.
    Kinoshita J; Fushida S; Tsukada T; Oyama K; Okamoto K; Makino I; Nakamura K; Miyashita T; Tajima H; Takamura H; Ninomiya I; Ohta T
    Eur J Surg Oncol; 2015 Oct; 41(10):1354-60. PubMed ID: 26028256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of S-1 plus Cisplatin Neoadjuvant Chemotherapy on Scirrhous Gastric Cancer.
    Kunisaki C; Makino H; Kimura J; Takagawa R; Kanazawa A; Ota M; Kosaka T; Ono HA; Akiyama H; Endo I
    Oncology; 2015; 88(5):281-8. PubMed ID: 25591954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of advanced gastric cancer responding to combined systemic and intraperitoneal chemotherapy with docetaxel, cisplatin, and S-1].
    Yasui T; Mukubo H; Sato N; Kita I; Fushida S
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2229-31. PubMed ID: 24394068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Highly advanced gastric cancer that responded to neoadjuvant combination chemotherapy with docetaxel/CDDP/S-1 (DCS)].
    Egawa T; Kenmochi T; Ohashi M; Irino T; Mihara K; Okamura A; Inaba Y; Ito Y; Hayashi S; Nagashima A
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2470-2. PubMed ID: 21224609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Dissection after Neoadjuvant Chemotherapy].
    Ogawa T; Choda Y; Ninomiya M; Nagai Y; Mimura N; Miyake S; Ishida M; Matsukawa H; Ojima Y; Idani H; Shiozaki S; Okajima M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2205-2207. PubMed ID: 28133270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.
    Hirakawa M; Sato Y; Ohnuma H; Takayama T; Sagawa T; Nobuoka T; Harada K; Miyamoto H; Sato Y; Takahashi Y; Katsuki S; Hirayama M; Takahashi M; Ono M; Maeda M; Takada K; Hayashi T; Sato T; Miyanishi K; Takimoto R; Kobune M; Hirata K; Kato J
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):789-97. PubMed ID: 23338051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of preoperative chemotherapy with docetaxel, cisplatin and S-1 for T4 locally advanced gastric cancer.
    Fushida S; Nashimoto A; Fukushima N; Kawachi Y; Fujimura T; Kuwabara S; Musha N;
    Jpn J Clin Oncol; 2012 Feb; 42(2):131-3. PubMed ID: 22167664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A Phase Ⅱ Study of Systemic Chemotherapy with Capecitabine and Cisplatin Followed by Surgery for Advanced Gastric Cancer with Extensive Lymph Node Metastasis(OGSG1401)].
    Takeno A; Kimura Y; Sugimoto N; Hirao M; Akiyoshi K; Murakami K; Sakai D; Shimokawa T; Kurokawa Y; Sato T
    Gan To Kagaku Ryoho; 2020 Mar; 47(3):481-483. PubMed ID: 32381922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.